Mylan Inc (MYL) 51.25 $MYL
The Zacks Analyst Blog Highlights: TAL Education, Mylan, Nevro, Chefs' Warehouse and ServiceMaster Global Holdings
Zacks Equity Research - Zacks Investment Research - Tue Nov 17, 8:30AM CST
The Zacks Analyst Blog Highlights: TAL Education, Mylan, Nevro, Chefs' Warehouse and ServiceMaster Global Holdings
CHEF: 19.51 (-0.23), MYL: 51.25 (+1.25), SERV: 35.52 (-0.10), XRS: 41.36 (+0.31), NVRO: 51.97 (+1.04)
Mylan Launches Generic AXERT® Tablets
PR Newswire - Tue Nov 17, 6:30AM CST
Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Almotriptan Tablets USP, 6.25 mg and 12.5 mg, the generic version of Janssen Pharmaceutical's AXERT®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is used for the acute treatment of migraine attacks in adult patients with a history of migraine with or without aura. In adolescents age 12 to 17 years, it is indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated).
MYL: 51.25 (+1.25)
Mylan unveils generic Viramune XR Extended-Release HIV-1Tablets, 100 mg
M2 - Tue Nov 17, 3:36AM CST
Pharmaceutical company Mylan NV (NASDAQ:MYL)(TASE:MYL) revealed on Monday the availability of Nevirapine Extended-release Tablets, 100 mg, in the US market.
MYL: 51.25 (+1.25)
Mylan introduces generic GLUCOTROL XL Tablets for patients with type 2 diabetes mellitus
M2 - Tue Nov 17, 3:31AM CST
Pharmaceutical company Mylan NV (NASDAQ:MYL) (TASE:MYL) said on Monday that it has launched the Glipizide Extended-release Tablets, 5 mg and 10 mg in the US market.
MYL: 51.25 (+1.25)
Mylan's board approves USD1bn share repurchase programme
M2 - Tue Nov 17, 3:26AM CST
The board of directors of Mylan NV (NASDAQ:MYL)(TASE:MYL) on Monday declared the repurchase of up to USD1bn of its ordinary share in the open market through privately-negotiated transactions or in one or more self tender offers.
MYL: 51.25 (+1.25)
After Yesterday's Rally of 2.50% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 16, 3:42PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $48.40 to a high of $50.51. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $49.49 on volume of 11.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 51.25 (+1.25)
Mylan Set to Possibly Pullback After Yesterday's Rally of 2.50%
Comtex SmarTrend(R) - Mon Nov 16, 3:41PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $48.40 to a high of $50.51. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $49.49 on volume of 11.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 51.25 (+1.25)
The Medicines Co. Up, Angiomax Patent Ruling Overturned
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 3:40PM CST
The Medicines Company's (MDCO) request for rehearing of the appeal has been granted related to its patent infringement lawsuit for Angiomax.
MDCO: 41.08 (-0.43), PFE: 33.28 (+0.12), MYL: 51.25 (+1.25), NVS: 87.82 (+0.77)
Look Past the Downturn: 5 Stocks That Rallied Over 5%
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 3:29PM CST
With the help of the Zacks Stock Screener, we have zeroed-in on five stocks that have rallied an impressive 5% or more over the last one week, and also flaunt a solid Zacks Rank
CHEF: 19.51 (-0.23), MYL: 51.25 (+1.25), SERV: 35.52 (-0.10), XRS: 41.36 (+0.31), NVRO: 51.97 (+1.04)
Mylan's Acquisition Offer Fails to Woo Perrigo Shareholders
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 3:25PM CST
Mylan (MYL) announced that its offer to acquire all share capital of Perrigo Company plc (PRGO) has lapsed.
PRGO: 153.04 (+4.04), GWPH: 84.64 (+1.98), CNAT: 3.40 (-0.24), MYL: 51.25 (+1.25)
Stocks Rally to Close Higher After Choppy Start
at The Street - Mon Nov 16, 3:01PM CST
Stocks ended Monday on a high note, closing with gains, despite starting off choppy after the terrorist attacks in Paris.
CCL: 50.96 (+0.19), DAL: 48.53 (+0.60), WMT: 60.14 (+2.27), BBY: 30.76 (-0.87), NXST: 59.59 (+0.96), HOT: 72.43 (+0.16), T: 33.36 (+0.32), TGT: 73.12 (+0.81), AAL: 42.70 (-0.13), GOOGL: 752.29 (+1.87), AAPL: 114.36 (+0.18), HD: 126.06 (+5.22), MYL: 51.25 (+1.25), BAC: 17.54 (+0.11), MAR: 73.53 (-0.19), PCLN: 1,262.65 (-4.22), DDS: 73.12 (+0.60), URBN: 21.10 (-1.57), GS: 192.28 (+0.12), MEG: 15.29 (-0.09), CLVS: 27.54 (-2.70), GM: 35.30 (+0.13), JD: 29.12 (+0.31), BRK.A: 200,564.96 (+764.96), BABA: 78.20 (-0.10)
Weak Chinese Demand Is Already Priced Into Caterpillar's Stock (Plus: MYL, T, DRG, URBN)
at The Street - Mon Nov 16, 2:15PM CST
CAT not going down on bearish news gets us closer to a bottom and buy recommendation.
ZTS: 46.07 (+0.77), URBN: 21.10 (-1.57), T: 33.36 (+0.32), MYL: 51.25 (+1.25), BMY: 66.08 (+1.06), CAT: 69.79 (-0.60), ALKS: 74.70 (+1.50)
Stocks Are Trading Near Session Highs
at The Street - Mon Nov 16, 1:37PM CST
Stocks are trading near session highs Monday afternoon.
HD: 126.06 (+5.22), CCL: 50.96 (+0.19), DAL: 48.53 (+0.60), BBY: 30.76 (-0.87), WMT: 60.14 (+2.27), MYL: 51.25 (+1.25), BAC: 17.54 (+0.11), NXST: 59.59 (+0.96), MAR: 73.53 (-0.19), PCLN: 1,262.65 (-4.22), HOT: 72.43 (+0.16), URBN: 21.10 (-1.57), DDS: 73.12 (+0.60), T: 33.36 (+0.32), GS: 192.28 (+0.12), MEG: 15.29 (-0.09), CLVS: 27.54 (-2.70), TGT: 73.12 (+0.81), GM: 35.30 (+0.13), GOOGL: 752.29 (+1.87), JD: 29.12 (+0.31), AAPL: 114.36 (+0.18), BRK.A: 200,564.96 (+764.96), BABA: 78.20 (-0.10)
No Snake Oil in These 4 Pharmaceutical Picks (Plus: T, DRG, URBN)
at The Street - Mon Nov 16, 1:15PM CST
These candidates have what I consider to be the strongest technical profiles.
ZTS: 46.07 (+0.77), URBN: 21.10 (-1.57), T: 33.36 (+0.32), MYL: 51.25 (+1.25), BMY: 66.08 (+1.06), ALKS: 74.70 (+1.50)
No Snake Oil in These Four Pharmaceutical Picks (Plus: T, DRG, URBN)
at The Street - Mon Nov 16, 1:15PM CST
These candidates have what I consider to be the strongest technical profiles.
ZTS: 46.07 (+0.77), URBN: 21.10 (-1.57), T: 33.36 (+0.32), MYL: 51.25 (+1.25), BMY: 66.08 (+1.06), ALKS: 74.70 (+1.50)
Mylan (MYL) Stock Climbs on $1 Billion Stock Buyback
at The Street - Mon Nov 16, 1:13PM CST
Mylan (MYL) stock is advancing in afternoon trading on Monday, after announcing a share repurchase worth as much as $1 billion.
MYL: 51.25 (+1.25)
Mylan (MYL) Crosses Pivot Point Resistance at $50.02
Comtex SmarTrend(R) - Mon Nov 16, 12:37PM CST
Mylan (NASDAQ:MYL) has opened bullishly above the pivot of $48.25 today and has reached the first level of resistance at $50.02. Analysts will be watching for a cross of the next upside pivot targets of $51.26 and $54.27.
MYL: 51.25 (+1.25)
Mylan Authorizes $1 Billion Share Repurchase Plan
PR Newswire - Mon Nov 16, 10:40AM CST
Mylan N.V. (NASDAQ, TASE; MYL) today announced that the Board of Directors of Mylan N.V. (the "Company"
has authorized share repurchases by the Company of its ordinary shares in an amount up to $1 billion, either in the open market through privately-negotiated transactions or in one or more self tender offers. The repurchase program does not obligate the Company to acquire any particular amount of ordinary shares. The authorization expires on Aug. 27, 2016.
MYL: 51.24 (+1.24)
Stocks Turn Mixed in Choppy Trading
at The Street - Mon Nov 16, 10:23AM CST
Stock turn mixed Monday following the deadly terror attacks in Paris on Friday.
HD: 126.03 (+5.19), CCL: 50.96 (+0.19), DAL: 48.53 (+0.60), MYL: 51.24 (+1.24), WMT: 60.14 (+2.27), BBY: 30.76 (-0.87), BAC: 17.54 (+0.11), MAR: 73.54 (-0.18), PCLN: 1,262.65 (-4.22), HOT: 72.43 (+0.16), DDS: 73.12 (+0.60), URBN: 21.10 (-1.57), T: 33.36 (+0.32), GS: 192.28 (+0.12), TGT: 73.13 (+0.82), GM: 35.30 (+0.13), GOOGL: 752.29 (+1.87), JD: 29.12 (+0.31), BRK.A: 200,564.96 (+764.96), AAPL: 114.36 (+0.18), BABA: 78.20 (-0.10)
Will Mylan (MYL) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 9:12AM CST
As of late, it has definitely been a great time to be an investor in Mylan N.V. (MYL)
MYL: 51.24 (+1.24)
The Zacks Analyst Blog Highlights: TAL Education, Mylan, Nevro, Chefs' Warehouse and ServiceMaster Global Holdings
Zacks Equity Research - Zacks Investment Research - Tue Nov 17, 8:30AM CST
The Zacks Analyst Blog Highlights: TAL Education, Mylan, Nevro, Chefs' Warehouse and ServiceMaster Global Holdings
CHEF: 19.51 (-0.23), MYL: 51.25 (+1.25), SERV: 35.52 (-0.10), XRS: 41.36 (+0.31), NVRO: 51.97 (+1.04)
Mylan Launches Generic AXERT® Tablets
PR Newswire - Tue Nov 17, 6:30AM CST
Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Almotriptan Tablets USP, 6.25 mg and 12.5 mg, the generic version of Janssen Pharmaceutical's AXERT®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is used for the acute treatment of migraine attacks in adult patients with a history of migraine with or without aura. In adolescents age 12 to 17 years, it is indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated).
MYL: 51.25 (+1.25)
Mylan unveils generic Viramune XR Extended-Release HIV-1Tablets, 100 mg
M2 - Tue Nov 17, 3:36AM CST
Pharmaceutical company Mylan NV (NASDAQ:MYL)(TASE:MYL) revealed on Monday the availability of Nevirapine Extended-release Tablets, 100 mg, in the US market.
MYL: 51.25 (+1.25)
Mylan introduces generic GLUCOTROL XL Tablets for patients with type 2 diabetes mellitus
M2 - Tue Nov 17, 3:31AM CST
Pharmaceutical company Mylan NV (NASDAQ:MYL) (TASE:MYL) said on Monday that it has launched the Glipizide Extended-release Tablets, 5 mg and 10 mg in the US market.
MYL: 51.25 (+1.25)
Mylan's board approves USD1bn share repurchase programme
M2 - Tue Nov 17, 3:26AM CST
The board of directors of Mylan NV (NASDAQ:MYL)(TASE:MYL) on Monday declared the repurchase of up to USD1bn of its ordinary share in the open market through privately-negotiated transactions or in one or more self tender offers.
MYL: 51.25 (+1.25)
After Yesterday's Rally of 2.50% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 16, 3:42PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $48.40 to a high of $50.51. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $49.49 on volume of 11.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 51.25 (+1.25)
Mylan Set to Possibly Pullback After Yesterday's Rally of 2.50%
Comtex SmarTrend(R) - Mon Nov 16, 3:41PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $48.40 to a high of $50.51. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $49.49 on volume of 11.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 51.25 (+1.25)
The Medicines Co. Up, Angiomax Patent Ruling Overturned
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 3:40PM CST
The Medicines Company's (MDCO) request for rehearing of the appeal has been granted related to its patent infringement lawsuit for Angiomax.
MDCO: 41.08 (-0.43), PFE: 33.28 (+0.12), MYL: 51.25 (+1.25), NVS: 87.82 (+0.77)
Look Past the Downturn: 5 Stocks That Rallied Over 5%
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 3:29PM CST
With the help of the Zacks Stock Screener, we have zeroed-in on five stocks that have rallied an impressive 5% or more over the last one week, and also flaunt a solid Zacks Rank
CHEF: 19.51 (-0.23), MYL: 51.25 (+1.25), SERV: 35.52 (-0.10), XRS: 41.36 (+0.31), NVRO: 51.97 (+1.04)
Mylan's Acquisition Offer Fails to Woo Perrigo Shareholders
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 3:25PM CST
Mylan (MYL) announced that its offer to acquire all share capital of Perrigo Company plc (PRGO) has lapsed.
PRGO: 153.04 (+4.04), GWPH: 84.64 (+1.98), CNAT: 3.40 (-0.24), MYL: 51.25 (+1.25)
Stocks Rally to Close Higher After Choppy Start
at The Street - Mon Nov 16, 3:01PM CST
Stocks ended Monday on a high note, closing with gains, despite starting off choppy after the terrorist attacks in Paris.
CCL: 50.96 (+0.19), DAL: 48.53 (+0.60), WMT: 60.14 (+2.27), BBY: 30.76 (-0.87), NXST: 59.59 (+0.96), HOT: 72.43 (+0.16), T: 33.36 (+0.32), TGT: 73.12 (+0.81), AAL: 42.70 (-0.13), GOOGL: 752.29 (+1.87), AAPL: 114.36 (+0.18), HD: 126.06 (+5.22), MYL: 51.25 (+1.25), BAC: 17.54 (+0.11), MAR: 73.53 (-0.19), PCLN: 1,262.65 (-4.22), DDS: 73.12 (+0.60), URBN: 21.10 (-1.57), GS: 192.28 (+0.12), MEG: 15.29 (-0.09), CLVS: 27.54 (-2.70), GM: 35.30 (+0.13), JD: 29.12 (+0.31), BRK.A: 200,564.96 (+764.96), BABA: 78.20 (-0.10)
Weak Chinese Demand Is Already Priced Into Caterpillar's Stock (Plus: MYL, T, DRG, URBN)
at The Street - Mon Nov 16, 2:15PM CST
CAT not going down on bearish news gets us closer to a bottom and buy recommendation.
ZTS: 46.07 (+0.77), URBN: 21.10 (-1.57), T: 33.36 (+0.32), MYL: 51.25 (+1.25), BMY: 66.08 (+1.06), CAT: 69.79 (-0.60), ALKS: 74.70 (+1.50)
Stocks Are Trading Near Session Highs
at The Street - Mon Nov 16, 1:37PM CST
Stocks are trading near session highs Monday afternoon.
HD: 126.06 (+5.22), CCL: 50.96 (+0.19), DAL: 48.53 (+0.60), BBY: 30.76 (-0.87), WMT: 60.14 (+2.27), MYL: 51.25 (+1.25), BAC: 17.54 (+0.11), NXST: 59.59 (+0.96), MAR: 73.53 (-0.19), PCLN: 1,262.65 (-4.22), HOT: 72.43 (+0.16), URBN: 21.10 (-1.57), DDS: 73.12 (+0.60), T: 33.36 (+0.32), GS: 192.28 (+0.12), MEG: 15.29 (-0.09), CLVS: 27.54 (-2.70), TGT: 73.12 (+0.81), GM: 35.30 (+0.13), GOOGL: 752.29 (+1.87), JD: 29.12 (+0.31), AAPL: 114.36 (+0.18), BRK.A: 200,564.96 (+764.96), BABA: 78.20 (-0.10)
No Snake Oil in These 4 Pharmaceutical Picks (Plus: T, DRG, URBN)
at The Street - Mon Nov 16, 1:15PM CST
These candidates have what I consider to be the strongest technical profiles.
ZTS: 46.07 (+0.77), URBN: 21.10 (-1.57), T: 33.36 (+0.32), MYL: 51.25 (+1.25), BMY: 66.08 (+1.06), ALKS: 74.70 (+1.50)
No Snake Oil in These Four Pharmaceutical Picks (Plus: T, DRG, URBN)
at The Street - Mon Nov 16, 1:15PM CST
These candidates have what I consider to be the strongest technical profiles.
ZTS: 46.07 (+0.77), URBN: 21.10 (-1.57), T: 33.36 (+0.32), MYL: 51.25 (+1.25), BMY: 66.08 (+1.06), ALKS: 74.70 (+1.50)
Mylan (MYL) Stock Climbs on $1 Billion Stock Buyback
at The Street - Mon Nov 16, 1:13PM CST
Mylan (MYL) stock is advancing in afternoon trading on Monday, after announcing a share repurchase worth as much as $1 billion.
MYL: 51.25 (+1.25)
Mylan (MYL) Crosses Pivot Point Resistance at $50.02
Comtex SmarTrend(R) - Mon Nov 16, 12:37PM CST
Mylan (NASDAQ:MYL) has opened bullishly above the pivot of $48.25 today and has reached the first level of resistance at $50.02. Analysts will be watching for a cross of the next upside pivot targets of $51.26 and $54.27.
MYL: 51.25 (+1.25)
Mylan Authorizes $1 Billion Share Repurchase Plan
PR Newswire - Mon Nov 16, 10:40AM CST
Mylan N.V. (NASDAQ, TASE; MYL) today announced that the Board of Directors of Mylan N.V. (the "Company"
has authorized share repurchases by the Company of its ordinary shares in an amount up to $1 billion, either in the open market through privately-negotiated transactions or in one or more self tender offers. The repurchase program does not obligate the Company to acquire any particular amount of ordinary shares. The authorization expires on Aug. 27, 2016. MYL: 51.24 (+1.24)
Stocks Turn Mixed in Choppy Trading
at The Street - Mon Nov 16, 10:23AM CST
Stock turn mixed Monday following the deadly terror attacks in Paris on Friday.
HD: 126.03 (+5.19), CCL: 50.96 (+0.19), DAL: 48.53 (+0.60), MYL: 51.24 (+1.24), WMT: 60.14 (+2.27), BBY: 30.76 (-0.87), BAC: 17.54 (+0.11), MAR: 73.54 (-0.18), PCLN: 1,262.65 (-4.22), HOT: 72.43 (+0.16), DDS: 73.12 (+0.60), URBN: 21.10 (-1.57), T: 33.36 (+0.32), GS: 192.28 (+0.12), TGT: 73.13 (+0.82), GM: 35.30 (+0.13), GOOGL: 752.29 (+1.87), JD: 29.12 (+0.31), BRK.A: 200,564.96 (+764.96), AAPL: 114.36 (+0.18), BABA: 78.20 (-0.10)
Will Mylan (MYL) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 9:12AM CST
As of late, it has definitely been a great time to be an investor in Mylan N.V. (MYL)
MYL: 51.24 (+1.24)
